1.990USD-3.86%Mkt Cap: 70.75M USDP/E: 4.63Last update: 2026-05-22
biote Corp. operates in practice-building business within the hormone optimization space. It trains physicians and nurse practitioners in hormone optimization using bioidentical hormone replacement pellet therapy in men …
Industry Peers
Medical Care Facilities89.61BTRYP/E 15.8
87.42BUSDP/E 13.6
31.71BSEKP/E 36.8
21.84BEURP/E 14.5
16.19BSEKP/E 19.2
12.74BUSDP/E 19.1
11.90BSEKP/E 17.4
10.01BEURP/E 11.4
loading…
Indicators:|
Key Statistics
Company
Market Cap70.75M USD
Enterprise Value174.02M USD
Revenue (TTM)188.16M USD
Gross Profit137.36M USD
Net Income (TTM)27.05M USD
Revenue/Share6.055 USD
Last Price1.990 USD
Fiscal Year EndDec 2025
MR QuarterMar 2026
Employees223
CountryUS
SectorHealthcare
IndustryMedical Care Facilities
ISIN—
Valuation
P/E (Trailing)4.63
P/E (Forward)3.63
PEG—
EV/EBITDA5.30
EV/Revenue0.92
P/S0.39
P/B-1.11
EPS (TTM)0.43
EPS (Forward)0.57
52W Range
1.27021% of range4.750
52W High4.750 USD
52W Low1.270 USD
Profitability
Gross Margin71.46%
Oper. Margin9.78%
EBITDA Margin17.46%
Profit Margin14.07%
ROE-46.20%
ROA25.13%
Growth
Revenue Growth-8.30%
Earnings Growth-83.80%
Cash Flow & Leverage
Operating CF35.19M USD
CapEx (TTM)6.86M USD
FCF Margin-2.52%
FCF Yield-6.69%
Net Debt103.10M USD
Net Debt/EBITDA3.14
Balance Sheet
Debt/Equity-1.88
Current Ratio1.29
Quick Ratio0.45
Book Value/Sh-1.8710 USD
Cash/Share0.1750 USD
Dividends
Fwd Div Rate—
Trail. Div Rate0.0000 USD
Div. Yield—
5Y Avg Yield—
Payout Ratio0.00%
Ex-Div Date—
Pay Date—
Analyst Consensus
Rating1.4 (Strong Buy)
Target (Mean)2.986 USD
Target Range2.000 USD – 4.000 USD
# Analysts5
Ownership
Shares Out.30.33M
Float19.62M
Insiders10.39%
Institutions66.55%
Short Interest
Short Ratio5.6d
Short % Float6.25%
Short % Out.4.63%
Shares Short1.48M
Short (prev mo.)1.59M
Technical
SMA 501.841 (+8.1%)
SMA 2002.474 (-19.5%)
Beta1.71
S&P 52W Chg28.31%
Avg Vol (30d)215.65K
Avg Vol (10d)249.75K
Technical Indicators
RSI (14)—
MACD—
MACD Signal—
MACD Hist.—
BB Upper—
BB Middle—
BB Lower—
BB Width—
ATR (14)—
Vol Ratio (20d)—